JFDA recalls batches of Diprofos injections over quality issues

(Photo: Twitter)
AMMAN — The Jordan Food and Drug Administration (JFDA) on Thursday announced a recall of specific batches of Diprofos injections, which are used to alleviate symptoms of asthma and allergies, after the manufacturer made remarks on the quality of those unique batches.اضافة اعلان

The recall is precautionary and will be conducted in coordination with the manufacturing company and its agent in Jordan, the JFDA said, expressing reassurance to the public regarding the effectiveness and safety of the product, which is imported to the local market, in batches that are not affected, the Jordan News Agency, Petra, reported.

The administration also noted that no reports have been made regarding any negative side effects from Diprofos.

According to JFDA Director-General Nizar Mheidat, the recall includes batches bearing the serial numbers W037168, W037404, W030686, W032602, W030457, W025759, W004660, U039526, U037740, U039364, U039650, and U028276.

Mheidat also affirmed that medicines imported to the Kingdom are tested by the JFDA before being distributed in the local market.

Read more National news
Jordan News